Andrew J. Armanino, Director at Better Therapeutics, Inc. (BTTX), bought 40,000 shares at $2.14 ($86K) on 2022-03-29, disclosed to the SEC on 2022-03-31.
Open-market purchase of $86k BTTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BTTX | BUY | 2023-04-12 | $503K | — | Filing → |
| BTTX | BUY | 2022-06-16 | $21K | — | Filing → |
| BTTX | BUY | 2022-06-10 | $41K | — | Filing → |